← Back to Search

Focused Ultrasound

Transcranial Focused Ultrasound for Depression and Anxiety

N/A
Waitlist Available
Led By Sheldon Jordan, M.D.
Research Sponsored by Neurological Associates of West Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years of age
Failure to remit with 3 anxiolytics
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline prior to ultrasound administration
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether transcranial ultrasound is a safe and effective treatment for patients with depression and anxiety that has not responded to other treatments.

Who is the study for?
This trial is for adults who have tried at least three antidepressants and anxiolytics without improvement, have a diagnosis of Major Depressive Disorder or Generalized/Acute Anxiety Disorder, and score high on anxiety and depression scales.
What is being tested?
The study is testing the use of transcranial focused ultrasound as a treatment. It's an open label study, meaning everyone knows they're getting the treatment, to see if it helps with severe depression and anxiety.
What are the potential side effects?
Since this summary doesn't provide specific side effects of transcranial focused ultrasound, generally such treatments may cause discomfort at the site of application, headache or dizziness during or after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have tried 3 different anxiety medications without success.
Select...
I have tried 3 antidepressants without success.
Select...
I have been diagnosed with Major Depressive Disorder.
Select...
I have been diagnosed with Generalized or Acute Anxiety Disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after final ultrasound (8 weeks from baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and after final ultrasound (8 weeks from baseline) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Beck Anxiety Inventory
Beck Depression Inventory
Hamilton Anxiety Rating Scale
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
All patients enrolled will receive transcranial focused ultrasound. Target location is dependent on patient condition.

Find a Location

Who is running the clinical trial?

Neurological Associates of West Los AngelesLead Sponsor
25 Previous Clinical Trials
3,860 Total Patients Enrolled
4 Trials studying Depression
730 Patients Enrolled for Depression
Sheldon Jordan, M.D.Principal InvestigatorNeurological Associates - the Interventional Group
4 Previous Clinical Trials
815 Total Patients Enrolled
2 Trials studying Depression
700 Patients Enrolled for Depression

Media Library

Transcranial Focused Ultrasound (Focused Ultrasound) Clinical Trial Eligibility Overview. Trial Name: NCT04250441 — N/A
Depression Research Study Groups: Treatment
Depression Clinical Trial 2023: Transcranial Focused Ultrasound Highlights & Side Effects. Trial Name: NCT04250441 — N/A
Transcranial Focused Ultrasound (Focused Ultrasound) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04250441 — N/A
~14 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top